• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Study finds progressive declines in vision in aging patients with diffractive multifocal IOLs

Article

According to investigators, patients implanted with diffractive multifocal IOLs had notable declines in the corrected distance visual acuity, distance corrected near VA, and near area of focus with aging

Patients implanted with diffractive multifocal IOLs had notable declines in the corrected distance visual acuity (CDVA), distance corrected near VA (DCNVA), and near area of focus (AoF) with aging, according to Ryo Terauchi, MD, and associates from the Department of Ophthalmology at the Jikei University School of Medicine in Tokyo, Japan.

The investigators compared the effects of aging in this patient population by dividing patients who had been implanted with diffractive multifocal IOLs into the following 4 groups: those under 50 years of age, 50 to 59 years, 60 to 69 years, and 70 to 79 years.

The CDVA, DCNVA, and an area of focus metric, i.e., the distance, intermediate, and near AoF were measured postoperatively and compared among the age groups.

Age group comparisons

The respective CDVAs in the 4 age groups declined with age: −0.18, −0.16, −0.14, and −0.10 logarithm of the minimum angle of resolution (logMAR). In patients in their 70s, the CDVA was significantly worse compared with those younger than 50 years and those in their 50s (p = 0.002 and p = 0.049, respectively), Dr. Terauchi reported.

He also reported that the respective DCNVAs in the 4 age groups showed the same trend: 0.01, 0.03, 0.03, and 0.08 logMAR. The DCNVA in the oldest group was significantly worse than those in patients younger than 50 years and those in their 60s (p = 0.008 and p = 0.019, respectively).

Finally, the near AoF was smaller in the oldest patients compared with the patients younger than 50 years and those patients in their 50s (p = 0.040 and p = 0.047, respectively). No significant differences were seen in the intermediate and distant AoFs in the 4 groups. However, in patients over 60 years of age, a “steep” decline was seen in the AoF.

Reference

Terauchi R, Horiguchi H, Ogawa S, et al. Age-related visual outcomes in eyes with diffractive multifocal intraocular lenses. Eye 2021; https://doi.org/10.1038/s41433-021-01854-x

Related Videos
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
CIME 2024: Neda Shamie, MD, reports on a morning session packed with refractive surgery options, retina, glaucoma, and a 'mite-y' Demodex discussion
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
Elizabeth Yeu, MD, highlights from a corneal case report for a patient undergoing the triple procedure
© 2024 MJH Life Sciences

All rights reserved.